Bank of America’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-532,671
| Closed | -$60K | – | 7655 |
|
|
2018
Q4 | $60K | Buy |
532,671
+483,665
| +987% | +$317K | ﹤0.01% | 6152 |
|
|
2018
Q3 | $83K | Sell |
49,006
-194,357
| -80% | -$348K | ﹤0.01% | 5975 |
|
|
2018
Q2 | $423K | Sell |
243,363
-15,915
| -6% | -$27.5K | ﹤0.01% | 4997 |
|
|
2018
Q1 | $475K | Buy |
259,278
+204,478
| +373% | +$432K | ﹤0.01% | 4848 |
|
|
2017
Q4 | $123K | Sell |
54,800
-33,445
| -38% | -$83.1K | ﹤0.01% | 5658 |
|
|
2017
Q3 | $256K | Buy |
88,245
+38,712
| +78% | +$132K | ﹤0.01% | 5274 |
|
|
2017
Q2 | $220K | Sell |
49,533
-55,320
| -53% | -$228K | ﹤0.01% | 5269 |
|
|
2017
Q1 | $489K | Buy |
104,853
+45,554
| +77% | +$264K | ﹤0.01% | 4898 |
|
|
2016
Q4 | $361K | Buy |
59,299
+33,037
| +126% | +$173K | ﹤0.01% | 5014 |
|
|
2016
Q3 | $145K | Sell |
26,262
-12,381
| -32% | -$58K | ﹤0.01% | 5278 |
|
|
2016
Q2 | $147K | Buy |
38,643
+16,329
| +73% | +$55.3K | ﹤0.01% | 5362 |
|
|
2016
Q1 | $62K | Sell |
22,314
-21,533
| -49% | -$78K | ﹤0.01% | 5700 |
|
|
2015
Q4 | $248K | Buy |
43,847
+15,821
| +56% | +$96.4K | ﹤0.01% | 5254 |
|
|
2015
Q3 | $149K | Sell |
28,026
-2,254
| -7% | -$17.4K | ﹤0.01% | 5489 |
|
|
2015
Q2 | $251K | Buy |
30,280
+15,005
| +98% | +$72.7K | ﹤0.01% | 5126 |
|
|
2015
Q1 | $70K | Sell |
15,275
-15,244
| -50% | -$49.6K | ﹤0.01% | 5503 |
|
|
2014
Q4 | $93K | Sell |
30,519
-36,372
| -54% | -$108K | ﹤0.01% | 5945 |
|
|
2014
Q3 | $187K | Sell |
66,891
-52,478
| -44% | -$190K | ﹤0.01% | 5447 |
|
|
2014
Q2 | $485K | Buy |
119,369
+66,869
| +127% | +$284K | ﹤0.01% | 4655 |
|
|
2014
Q1 | $279K | Buy |
52,500
+6,990
| +15% | +$39.2K | ﹤0.01% | 5139 |
|
|
2013
Q4 | $253K | Buy |
45,510
+28,281
| +164% | +$122K | ﹤0.01% | 5380 |
|
|
2013
Q3 | $78K | Sell |
17,229
-45,175
| -72% | -$203K | ﹤0.01% | 6157 |
|
|
2013
Q2 | $266K | Buy |
+62,404
| New | +$314K | ﹤0.01% | 5353 |
|
Other funds holding SGYP
Bank of America's SGYP Position: Q1 2019 in Review
Bank of America sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 532,671 shares — an estimated $60K sold.
Bank of America first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $489K in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Bank of America reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Bank of America sold 532,671 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $60K.
- Bank of America first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Bank of America's Synergy Pharmaceuticals, Inc Common Stock position peaked at $489K in Q1 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.